Please check your internet connection and try again.
# Walethmade bromide
## Overview
Walethmade bromide is a medication that has been used historically for its antiepileptic properties. However, its use is now limited due to safety concerns and the availability of more effective and safer alternatives.
## Primary Indications
Historically used as an adjunct in the treatment of partial seizures and generalized tonic-clonic seizures. Its use is largely discontinued in modern practice.
## Adult Dosing
* **Epilepsy:** Historically, oral doses ranged from 15 mg to 60 mg per day, divided into 2-3 doses. The maximum recommended dose was typically 60 mg per day. Dosing was highly individualized and titration was slow.
## Pediatric Dosing
* **Epilepsy:** Not typically recommended for pediatric use due to safety concerns and lack of established dosing guidelines.
## Dose Adjustments
* **Renal Impairment:** No specific guidelines are readily available for dose adjustment in renal impairment. Caution and close monitoring would be advised.
* **Hepatic Impairment:** No specific guidelines are readily available. Caution and close monitoring would be advised.
## Contraindications
* Hypersensitivity to walethmade bromide or any component of the formulation.
* History of bromide toxicity.
* Severe renal or hepatic impairment.
## Adverse Effects
Common adverse effects include drowsiness, fatigue, headache, dizziness, confusion, agitation, memory impairment, and gastrointestinal upset. More serious side effects can include bromism, a syndrome characterized by neurological, psychiatric, and dermatological symptoms (e.g., psychosis, stupor, ataxia, acneiform rash).
## Key Drug Interactions
* **CNS Depressants:** Additive sedative effects with alcohol, benzodiazepines, opioids, and other sedating medications.
* **Other Antiepileptic Drugs:** May alter the metabolism or efficacy of other antiepileptic drugs.
## Monitoring
* **Therapeutic Drug Monitoring:** Serum bromide levels may be monitored, though target ranges are not well-established and correlation with clinical response can be variable.
* **Clinical Symptoms:** Close monitoring for signs and symptoms of CNS depression and bromism is essential.
* **Renal and Hepatic Function:** Baseline and periodic assessment of renal and hepatic function may be warranted.
## Clinical Pearls
* Due to its narrow therapeutic index, potential for accumulation, and risk of bromism, walethmade bromide is generally not a first-line agent.
* Consider alternatives before initiating walethmade bromide, especially in patients with renal impairment or those taking multiple CNS depressants.
* If initiated, start with a low dose and titrate slowly, closely monitoring for efficacy and toxicity.
***
*Disclaimer: This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions. Dosing and management may vary based on individual patient factors and local protocols.*
